ArchaeaVolume 2012 (2012), Article ID 438931, 9 pagesdoi:10.1155/2012/438931

Research Article

Archaeal Phospholipid Biosynthetic Pathway Reconstructed in Escherichia coli

Takeru Yokoi, Keisuke Isobe, Tohru Yoshimura, and Hisashi Hemmi

Department of Applied Molecular Bioscience, Graduate School of Bioagricultural Sciences, Nagoya University, Furo-cho, Chikusa-ku, Nagoya, Aichi 460-8601, Japan

Received 19 December 2011; Accepted 23 February 2012

Academic Editor: Yosuke Koga

Copyright © 2012 Takeru Yokoi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

A part of the biosynthetic pathway of archaeal membrane lipids, comprised of 4 archaeal enzymes, was reconstructed in the cells of Escherichia coli. The genes of the enzymes were cloned from a mesophilic methanogen, Methanosarcina acetivorans, and the activity of each enzyme was confirmed using recombinant proteins. In vitro radioassay showed that the 4 enzymes are sufficient to synthesize an intermediate of archaeal membrane lipid biosynthesis, that is, 2,3-di-O-geranylgeranyl-sn-glycerol-1-phosphate, from precursors that can be produced endogenously in E. coli. Introduction of the 4 genes into E. coli resulted in the production of archaeal-type lipids. Detailed liquid chromatography/electron spray ionization-mass spectrometry analyses showed that they are metabolites from the expected intermediate, that is, 2,3-di-O-geranylgeranyl-sn-glycerol and 2,3-di-O-geranylgeranyl-sn-glycerol-1-phosphoglycerol. The metabolic processes, that is, dephosphorylation and glycerol modification, are likely catalyzed by endogenous enzymes of E. coli.

1. Introduction

Archaeal membrane lipids are very specific to the organisms in the domain Archaea and have structures that are distinct from those of bacterial/eukaryotic lipids [1–3]. Although they are, essentially, analogues of glycerolipids from bacteria or eukaryotes, they have specific structural features as follows: (1) hydrocarbon chains of archaeal lipids are multiply-branched isoprenoids typically derived from (all-E) geranylgeranyl diphosphate (GGPP), while linear acyl groups are general in bacterial/eukaryotic lipids; (2) the isoprenoid chains are linked with the glycerol moiety with ether bonds, while ester bonds are general in bacterial/eukaryotic lipids; (3) the glycerol moiety of archaeal lipids is derived from sn-glycerol-1-phosphate (G-1-P), which is the enantiomer of sn-glycerol-3-phosphate, the precursor for bacterial/eukaryotic glycerolipids; (4) dimerization of membrane lipids by the formation of carbon-carbon bonds between the ω-terminals of hydrocarbon chains, which generates macrocyclic structures such as caldarchaeol-type lipids with a typically 72-membered ring, is often observed in thermophilic and methanogenic archaea. These characteristics affect the properties of membranes formed with the lipids. In general, the permeability of membranes composed of archaeal lipids is lower than that of membranes that consist of bacterial/eukaryotic lipids [4, 5]. Moreover, the structural differences between archaeal and bacterial/eukaryotic lipids are believed to cause their black-and-white distribution between these domains without exception (the “lipid divide”) [6, 7]. This hypothesis is based on the idea that a membrane composed of both archaeal- and bacterial/eukaryotic-type lipids is disadvantageous to the organism, compared with membranes composed of one type. Although this hypothesis is attractive, no proof of it has been reported so far. To obtain proof of this hypothesis, two lines of experiments can be designed. One is to compare the physical properties of artificial membranes prepared with the archaeal- and/or bacterial/eukaryotic-type lipids. A few studies of this type have been done [8, 9]. Shimada and Yamagishi [9] recently reported that hybrid liposomes constructed from both archaeal- and bacterial-type lipids were generally more stable (impermeable) than they had expected. Based on these results, they concluded that the common ancestor of life (and the origin of eukaryotes supposedly formed by the fusion of archaea- and bacteria-like cells) might have had such hybrid lipid membranes, but they did not explain how the lipid divide occurred. The other, more straightforward line of experiments is to generate an organism that synthesizes both archaeal- and bacterial/eukaryotic-type membrane lipids and therefore has hybrid membranes. If the hybrid membranes are disadvantageous for the organism because of properties such as stability, permeability, and fluidity, the organism may lower viability or become susceptible to stresses such as heat and osmotic shock. Lai et al. recently reported the construction of such an organism, although they did not determine its phenotypes [10]. In their study, phospholipid biosynthetic genes from a hyperthermophilic archaeon Archaeoglobus fulgidus were introduced into Escherichia coli. The authors demonstrated the synthesis of precursors for archaeal membrane lipids, that is, 3-O-geranylgeranyl-sn-glycerol-1-phosphate (GGGP) and 2,3-di-O-geranylgeranyl-sn-glycerol-1-phosphate (DGGGP), in the recombinant E. coli, based on the detection of corresponding alcohols from the lipid extract from the cells after phosphatase treatment. However, it was still unclear whether the archaeal-type lipids produced in the cells actually acted as the structural components of a membrane bilayer, because the authors did not show the intact structures of the lipids. Moreover, they did not describe the level of production of the archaeal-type lipids, which is also important to the evaluation of their effects on the membranes of E. coli.

In the present study, we reconstructed a part of the biosynthetic pathway of an archaeal phospholipid (Figure 1), which consisted of G-1-P dehydrogenase, GGPP synthase, GGGP synthase, and DGGGP synthase from a mesophilic methanogenic archaeon, Methanosarcina acetivorans, in E. coli. These enzymes can synthesize DGGGP from the endogenous precursors of isoprenoid in E. coli, that is, (all-E) farnesyl diphosphate (FPP), isopentenyl diphosphate (IPP), and dihydroxyacetone phosphate (DHAP). In addition, the enzymes from the mesophile were expected to have optimal activities at the growth temperature of E. coli, which would lead to high-level production of the archaeal phospholipid precursor and its derivatives. We evaluated the total amount and intact structures of the archaeal-type lipids extracted from the cells by liquid chromatography/electron spray ionization-mass spectrometry (LC/ESI-MS) analysis and showed that DGGGP was metabolized by enzymes endogenous to E. coli.

Figure 1: Biosynthetic pathway of archaeal-type lipids reconstructed in E. coli.

2. Materials and Methods

2.1. Materials

LKC-18F precoated, reversed-phase, thin-layer chromatography plates were purchased from Whatman, UK. FPP was donated by Drs. Kyozo Ogura and Tanetoshi Koyama, Tohoku University. [1-¹⁴C]IPP was purchased from American Radiolabeled Chemicals, USA. All other chemicals were of analytical grade.

2.2. General Procedures

Restriction enzyme digestions, transformations, and other standard molecular biological techniques were carried out as described by Sambrook et al. [11].

2.3. Cultivation of M. acetivorans

The M. acetivorans C2A (JCM 12185) strain was provided by the Japan Collection of Microorganisms (JCM), RIKEN BRC, through the Natural Bio-Resource Project of the MEXT, Japan. The mesophilic methanogenic archaeon was cultivated in a JCM 385 Methanosarcina acetivorans medium at 37°C and harvested at the log phase.

2.4. Construction of Plasmids Containing Phospholipid Biosynthetic Genes from M. acetivorans

The genome of M. acetivorans was extracted from the cells using a DNA extraction kit, ISOPLANT II (Nippon Gene). Each of the hypothetical genes for archaeal phospholipid biosynthesis, that is, MA3686, MA0606, MA3969, and MA0961, was amplified using the primers shown in Table 1, using the genome of M. acetivorans as a template, and using KOD DNA polymerase (Toyobo, Japan). The amplified DNA fragment was digested by restriction enzymes that recognize the sites in the primers and then inserted into the pBAD18 vector cut with the same restriction enzymes to construct the plasmid for expression of each archaeal enzyme, that is, pBAD-MA3686, pBAD-MA0606, pBAD-MA3969, and pBAD-MA0961.

Table 1: Primers used for plasmid construction.

Primers
Sequences (restriction enzymes that recognize the underlined sites)

For the construction of pBAD-MA0606

ma0606fw
GTAAAGAATTCAGATATAAGGAAATAGATGTGATGCTTATGATGCTTAT (EcoRI)

ma0606rv
GGTATTTCTAGATTGTATCCTTATTTTTCAGTATTCCCTTGCAATCA (XbaI)

For the construction of pBAD-MA3969

ma3969fw
TTATATAGCTAGCTATTAAAAATAAGGATAATTAATGCAGGTGGAAGCACACCT (NheI)

ma3969rv
GAAATGTCGACGATATATCTCCTTTTATTTTTAGCTTTTTATAGCTGATA (SalI)

For the construction of pBAD-MA0961

ma0961fw
ATAGAATTCAAGAAGATTATAATGTCTGCCGGAATAC (EcoRI)

ma0961rv
GATTCTAGATCATACACCGGCAATGAAAG (XbaI)

For the construction of pBAD-MA3686

ma3686fw
CTATTGAGCTCAAATAAAAGGAGATATATCATGAAATTGACCATCAATA (SacI)

ma3686rv
ATATTGGTACCATCTATTTCCTTATATCTTCAACTTATGACCTTTGTGA (KpnI)

For the construction of pBAD-ALB2 by amplification of ma0961

alb2fw
ACAATCTAGAGTCGAAGGAAGATTATAATGTCTGCCGGAATAC

alb2rv
ATGCCTGCAGGTCGACTCATACACCGGCAATGAAAG (SalI)

For the construction of pBAD-ALB3 by amplification of ma3969

alb3fw
CGGTGTATGAGTCGAAAGGAGTAATTAATGCAGGTGGAAGCACACCT

alb3rv
ATGCCTGCAGGTCGACTTAGCTTTTTATAGCTGATA (SalI)

For the construction of pBAD-ALB4 by amplification of ma3686

alb4fw
AAAAAGCTAAGTCGAAAGGAGATATATCATGAAATTGACCATCAATA

alb4rv
ATGCCTGCAGGTCGACTCAACTTATGACCTTTGTGA (SalI)

For the construction of plasmids for expression of multiple archaeal genes, an In-Fusion Advantage PCR cloning kit (Takara, Japan) was used according to the manufacturer’s instructions. The MA0961 gene was amplified using the primers shown in Table 1 and pBAD-MA0961 as a template. By the action of the In-Fusion enzyme, the amplified fragment was inserted into the plasmid pBAD-MA0606, which had been digested with SalI, to construct the plasmid pBAD-ALB2. Next, the MA3969 gene, which was amplified using the primers in Table 1 and pBAD-MA3969 as a template, was inserted into pBAD-ALB2 digested with SalI to construct pBAD-ALB3. The plasmid was then digested with SalI, and the MA3686 gene, amplified using the primers in Table 1 and pBAD-MA3686 as a template, was inserted to construct pBAD-ALB4.

2.5. Recombinant Expression of the Archaeal Enzymes

E. coli Top10, transformed with each plasmid containing a homologous gene for archaeal phospholipid biosynthesis, that is, pBAD-MA0606, pBAD-MA3969, pBAD-MA0961, pBAD-MA3686, or pBAD-ALB4, was cultivated at 37°C in 250 mL LB medium supplemented with 100 mg/L ampicillin. When the optical density at 660 nm of the culture reached 0.5, then 0.02% of L-arabinose was added for induction. After an additional 16 h incubation, the cells were harvested and disrupted by sonication in 5 mL of 100 mM 3-(N-morpholino)propanesulfonic acid (MOPS)-NaOH buffer, pH 7.0. The homogenates were centrifuged at 24,000 g for 30 min to recover the supernatants as a crude extract, which was used for enzyme assay.

2.6. In Vitro Assay for the Biosynthesis of Phospholipid Precursors

The assay mixture for prenyltransferases contained, in a final volume of 200 μL 0.2 nmol of [1-¹⁴C]IPP (2.04 GBq/mmol), 1 nmol of FPP, 2.0 μmol of MgCl₂, 20 μmol of MOPS-NaOH, pH 7.0, and suitable volumes of the crude extracts from E. coli containing pBAD-MA0606, pBAD-MA3969, or pBAD-MA0961. α-Glycerophosphate (racemic mixture) was added only to the mixtures containing MA3969.

The assay mixture for G-1-P dehydrogenase contained, in a final volume of 200 μL, 0.2 nmol of [1-¹⁴C]IPP (2.04 GBq/mmol), 1 nmol of FPP, 2.0 μmol of MgCl₂, 20 μmol of MOPS-NaOH, pH 7.0, and suitable volumes of the crude extracts from E. coli containing pBAD-MA0606, pBAD-MA3969, or pBAD-MA3686. If needed, 200 nmol of α-glycerophosphate or DHAP was added to the mixture.

In a final volume of 200 μL, the assay mixture for the 4 archaeal enzymes simultaneously expressed in E. coli contained, 0.2 nmol of [1-¹⁴C]IPP (2.04 GBq/mmol), 1 nmol of FPP, 200 nmol of DHAP, 2.0 μmol of MgCl₂, 20 μmol of MOPS-NaOH, pH 7.0, and a suitable volume of the crude extract from E. coli containing pBAD-ALB4.

After incubation at 37°C for 30 min, the reaction was stopped by chilling in an ice bath. 200 μL of water saturated with NaCl was added to the mixture, and then the products were extracted with 600 μL of 1-butanol saturated with NaCl-saturated water. They were treated with acid phosphatase according to the method of Fujii et al. [12], and the hydrolysates were extracted with n-pentane and analyzed by reversed-phase, thin-layer chromatography (TLC) using a precoated plate LKC-18F developed with acetone/H₂O (9 : 1). The distribution of radioactivity was detected using a BAS2000 bioimaging analyzer (Fujifilm, Japan). The authentic samples were prepared as described in our previous reports, using the enzymes from Sufolobus acidocaldarius and S. solfataricus [13].

2.7. Lipid Isolation from E. coli Harboring pBAD-ALB4

Lipid was extracted from 2 g of wet cells of E. coli harboring pBAD-ALB4, cultured as described above, except that induction with l-arabinose was performed for 18 h. The cells were dissolved with 15 mL of 1-butanol/75 mM ammonium water/ethanol (4 : 5 : 11). The mixture was heated to 70°C and shaken vigorously for 1 min. It was heated again at 70°C for 20 min and shaken vigorously again for 1 min. After cooling to room temperature, the mixture was centrifuged at 1,000 g for 10 min. The supernatant was recovered and dried under a stream of nitrogen at 55°C. The dried residue was then dissolved with 7.2 mL of 1-butanol/methanol/0.5 M acetate buffer, pH 4.6 (3 : 10 : 5). Lipids in the mixture were extracted with 3 mL n-pentane and dried under a stream of nitrogen at 55°C. The dried residue was then redissolved in 1 mL of methanol/2-propanol (1 : 1).

2.8. LC/ESI-MS Analysis

ESI-MS was performed with an Esquire 3000 ion trap system (Bruker Daltonics, USA). MS-parameters used were as follows: sheath gas, N₂ of 30 psi; dry gas, N₂ of 7.0 L·min⁻¹ at 320°C; scanning range, 50–1,000 m/z; scan speed, 13,000 m/z·sec⁻¹; ion charge control target, 50,000 or 20,000; maximum accumulation time, 100 ms; averages, 10; rolling averaging, 2. The system was equipped with an Agilent 1100 Series HPLC system (Agilent Technologies, USA) using UV detection at 210 nm and COSMOSIL Packed Column 5C₁₈-AR-II (2.0 × 150 mm, Nacalai, Japan). The mobile phase consisted of methanol/100 mg·L⁻¹ sodium acetate (9 : 1) or methanol/120 mg·L⁻¹ potassium acetate (9 : 1). The flow rate was 0.2 mL·min⁻¹.

2.9. Sodium Periodate Treatment

For sodium periodate treatment of 2,3-di-O-geranylgeranyl-sn-glycero-1-phosphoglycerol (DGGGP-Gro), the peak fraction from HPLC contained about 1 nmol of the mixture of DGGGP-Gro and 2,3-di-O-geranylgeranyl-sn-glycerol (DGGGOH), and 1 μmol sodium periodate was added to 1 mL of 1-butanol/75 mM ammonium water/ethanol (4 : 5 : 11). The mixture was reacted at 25°C for 1 h in the dark. The reaction was stopped by adding 1.5 μmol of glycerol. After 15 min, the product was extracted by 1 mL of n-pentane and dried with N₂. The dried residue was dissolved with 100 μL of methanol/2-propanol (1 : 1) and analyzed by LC/ESI-MS.

3. Results and Discussion

We first searched for and cloned the genes from a mesophilic, methanogenic archaeon, M. acetivorans, which encoded the closest homologues of the enzymes involved in the biosynthesis of archaeal membrane lipids. The homologue of G-1-P dehydrogenase, which shows 59% sequential identity with G-1-P dehydrogenase from Methanothermobacter thermautotrophicus [14], is encoded in the gene MA3686. The closest homologue of GGPP synthase, with 39% identity with the enzyme from S. acidocaldarius [15], is encoded in MA0606. The GGGP synthase homologue with 57% identity with the enzyme from M. thermautotrophicus [16] is encoded in MA3969. The closest homologue of DGGGP synthase, with 31% identity with the enzyme from S. solfataricus [13], is encoded in MA0961. Each of the genes, MA3686, MA0606, MA3969, and MA0961, was recombinantly expressed in E. coli. The cells of E. coli were disrupted and centrifuged to recover the supernatant as the crude extract. Then the enzyme activity in the crude extract was confirmed by radio-TLC assay. As shown in Figure 2(a), incubation of the crude extract from E. coli expressing MA0606 with FPP and [¹⁴C]IPP yielded a radiolabeled hydrophobic product, and treatment of the product with acid phosphatase produced a compound that comigrated with authentic (all-E) geranylgeraniol on a reversed-phase TLC plate (Rf = 0.60). Addition of the crude extract from E. coli expressing MA3969 and α-glycerophosphate to the reaction mixture resulted in the movement of the radiolabeled spot on TLC. The new spot (Rf = 0.68) comigrated with authentic 3-O-geranylgeranyl-sn-glycerol (GGGOH). The movement did not occur in the absence of α-glycerophosphate (data not shown). When the crude extract from E. coli expressing MA0961 was additionally mixed, new radiolabeled spots (Rf = 0.34 and 0.12) emerged on TLC, accompanied by diminishing radioactivity of the other spot. The spot with an Rf of 0.34 comigrated with authentic DGGGOH. These results indicate that MA0606, MA3969, and MA0961 encode, as expected from their homologies, GGPP synthase, GGGP synthase, and DGGGP synthase, respectively. The spot with an Rf of 0.12 was considered to have originated from an unknown modification of DGGGP catalyzed by enzymes contained in the crude extracts. To confirm G-1-P dehydrogenase activity in the crude extract of E. coli expressing MA3686, the extract was incubated with the crude extracts containing M. acetivorans GGPP synthase and GGGP synthase, DHAP, FPP, and [¹⁴C]IPP. The hydrophobic product was extracted, treated with phosphatase, and analyzed by TLC, giving a main spot that comigrated with GGGOH (Figure 2(b)). After removal of the crude extract of E. coli expressing MA3686 from the reaction mixture, the GGGOH spot became thinner, and a spot that comigrated with geranylgeraniol became the major spot. This result shows that MA3686 encodes G-1-P dehydrogenase. In contrast, removal of DHAP from the mixture did not change the TLC profile of the products, suggesting that a sufficient amount of DHAP existed in the reaction mixture, which contained cell extracts from E. coli. It is noteworthy that a small amount of GGGOH appears to be synthesized even in the absence of M. acetivorans G-1-P dehydrogenase. It is possible that the enzyme has only low affinity for sn-glycerol-3-phosphate, as has been reported with G-1-P-specific archaeal homologues [17–19].

(a)

(b)

Figure 2: In vitro assay of the archaeal enzymes for phospholipid biosynthesis. (a) Thin-layer radiochromatogram of the dephosphorylated products from the reactions with recombinant M. acetivorans GGPP synthase, GGGP synthase, and/or DGGGP synthase. The enzyme assays were performed using FPP, [¹⁴C]IPP, and α-glycerophosphate as the substrates. (b) Thin-layer radiochromatogram of the products from the reaction with recombinant M. acetivorans G-1-P dehydrogenase, coupled with GGPP synthase and GGGP synthase. FPP, [¹⁴C]IPP, and DHAP were used as the substrates. S.F., solvent front; Ori., origin.

We next constructed a plasmid vector containing the 4 archaeal genes, which formed an artificial operon in the order MA0606-MA0961-MA3969-MA3686, to reconstruct the biosynthetic pathway of archaeal phospholipid in E. coli. The activities of the enzymes were confirmed by in vitro radio-TLC assay. The cell extract from recombinant E. coli expressing the 4 archaeal genes showed activities related to the formation of DGGGP from DHAP, IPP, and FPP in vitro (Figure 3(a)), which indicated that the enzymes from M. acetivorans, that is, G-1-P dehydrogenase, GGPP synthase, GGGP synthase, and DGGGP synthase, were all expressed in the cells. In addition, a radioactive spot with a lower Rf value (~0.1) was observed. This spot probably corresponded with the one with an Rf of 0.12 observed in Figure 2(a). Because these spots accompanied the formation of DGGGP and because reaction mixtures for these assays contained cell extracts from E. coli, they were considered to arise from an unknown derivative of DGGGP, which might be formed through endogenous metabolic pathways in E. coli.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

Figure 3: Radio-TLC and LC/ESI-MS analyses of the archaeal-type lipids synthesized in E. coli. (a) Crude extract from E. coli harboring pBAD-ALB4 was incubated with FPP, [¹⁴C]IPP, and DHAP. Reversed-phase radio-TLC analysis of the products was performed after dephosphorylation. S.F., solvent front; Ori., origin. (b) LC profiles of lipids extracted from E. coli harboring pBAD-ALB4 (lower) or its parent plasmid, pBAD18 (upper). (c) Positive ESI-MS ion spectrum of a peak in (b) around 22 min. (d) and (e) MS/MS analyses of the ions in (c), with m/z of 659.6 and 835.6, respectively. (f) Positive ESI-MS ion spectrum of the LC peak corresponding with that analyzed in (c). Exclusively for this analysis, the elution buffer was changed from sodium based to potassium based. (g) Negative ESI-MS ion spectrum of a peak in (b) around 22 min. (h) MS/MS analysis of the ion in (g), with an m/z of 789.5.

Thus, we extracted lipids from the recombinant E. coli cells to confirm in vivo synthesis of the archaeal phospholipid precursors or their derivatives. The results of LC/ESI-MS analysis of the extract from E. coli containing pBAD-ALB4 showed a relatively broad LC peak of A₂₁₀, which eluted from the column at ~22 min (Figure 3(b)). This peak was absent in the analysis of the extract from E. coli containing the parent plasmid pBAD18. Specific ion peaks with m/z of 659.6 and 835.6 were detected through MS analysis of the peak in the positive ion mode (Figure 3(c)). These ions had similar but slightly different peak retention times, so the smaller ion was unlikely derived from fragmentation of the larger one. The smaller ion with m/z of 659.6 corresponded with [DGGGOH+Na]⁺. As shown in Figure 3(d), MS/MS analysis of the ion gave a fragment ion with an m/z of 385.0, which corresponded with [GGGOH+Na-2H]⁺. In addition, a smaller fragment ion with an m/z of 354.9, which corresponded with [GGGOH+Na-CH₂O]⁺, was detected. The fragmentation pattern supported the idea that the peak in Figure 3(b) contained DGGGOH, which probably synthesized by the action of the exogenous archaeal enzymes and endogenous phosphatases in E. coli. On the other hand, the MS/MS analysis of the larger ion with m/z of 835.6 found a fragment ion with an m/z of 659.6, suggesting that the parent ion contained the DGGGOH structure (Figure 3(e)). The MS/MS/MS analysis of the fragment ion with an m/z of 659.6 yielded fragment ions similar to those observed in Figure 3(d) (data not shown). We therefore presumed that the ion peak with an m/z of 835.6 was derived from the cationic bisodium salt of the phosphatidylglycerol-type derivative of DGGGP (DGGGP-Gro). To confirm this idea, the elution buffer for LC/ESI-MS was changed from one containing sodium acetate to one containing potassium acetate, and the same lipid extract was analyzed. As a result, an ion with m/z of 867.5, which corresponded well with that expected for the cationic bis-potassium salt of DGGGP-Gro, was detected instead (Figure 3(f)). In addition, MS analysis of the ion shown in Figure 3(b), in the negative ion mode, yielded an ion with m/z of 789.5, which corresponded with [DGGGP-Gro]⁻ (Figure 3(g)). MS/MS analysis of the ion showed a fragmentation ion with an m/z of 715.5, which is consistent with [DGGGP]⁻ (Figure 3(h)).

Moreover, we recovered the LC peak in Figure 3(b), which probably contained DGGGP-Gro, and treated the phospholipid with sodium periodate to confirm the structure of the polar head group. LC/ESI-MS analysis of the treated lipid with the elution buffer containing sodium acetate gave a positive ion with an m/z of 803.5 (Figure 4(a)), which was absent in the analysis of the untreated sample (Figure 4(b)). The emergence of this ion seemed to accompany the decline of the ion with an m/z of 835.5. The m/z of 803.5 corresponded well with the cationic bisodium salt of DGGGP modified with glycoaldehyde (2,3-di-O-geranylgeranyl-sn-glycero-1-phosphoglycoaldehyde), which had been expected as the product of the sodium periodate treatment of DGGGP-Gro (Figure 4(c)).

(a)

(b)

(c)

Figure 4: Sodium periodate treatment of DGGGP-Gro. (a) Positive ion spectrum from LC/ESI-MS analysis of the archaeal-type phospholipid postperiodate treatment and (b) preperiodate treatment. (c) The scheme of periodate treatment of DGGGP-Gro. R represents a geranylgeranyl group.

These results show that DGGGP, which should be synthesized from the precursors in E. coli cells by the action of the 4 exogenous archaeal enzymes, has been metabolized by endogenous E. coli enzymes to yield DGGGP-Gro. It is unclear whether the radioactive TLC spots with of ~0.1, observed in Figures 2(a) and 3(a), are derived from DGGGP-Gro. The archaeal-type phospholipid probably acts as a component of membranes in E. coli. Modification of phospholipids with glycerol is usual in E. coli, which produces phosphatidylglycerol as a major component of membrane phospholipids [20]. However, the most common phospholipid in the bacterium is phosphatidylethanolamine. The biosynthesis of these phospholipids starts from the cytidylation of phosphatidic acid, which yields CDP-diacylglycerol [21]. sn-Glycerol-3-phosphate or L-serine is then transferred to form phosphatidyl-sn-glycero-3-phosphate or phosphatidyl-L-serine, respectively. Dephosphorylation of the former intermediate yields phosphatidylglycerol, while decarboxylation of the latter yields phosphatidylethanolamine. If the formation of DGGGP-Gro proceeds through this pathway, the cytidyltransferase, sn-glycerol-3-phosphate transferase, and phosphatase of E. coli must accept the archaeal-type phospholipid as the substrate. However, the addition of CTP to the reaction mixture of the in vitro radio-TLC assay did not intensify the spot with an Rf of ~0.1 (data not shown). In contrast, the fact that DGGGP modified with ethanolamine (or serine) was not detected in the LC/ESI-MS analyses suggested that the L-serine transferase did not accept the archaeal-type substrate. In fact, E. coli phosphatidylserine synthase, which belongs to an enzyme superfamily different from that which includes archaeal phosphatidylserine synthases, reportedly does not accept CDP-activated DGGGOH [22]. If the cytidylation-dependent pathway does not work, which seems more likely, the inner membrane-periplasmic phosphoglyceroltransferase system [23, 24] may transfer the sn-1-phosphoglycerol group from the 6-(glycerophospho)-D-glucose moiety of osmoregulated periplasmic glucans “membrane derived oligosaccharides”, or their lipid-linked precursors, to DGGGOH to yield DGGGP-Gro directly.

It should be noted that the growth rate of E. coli harboring pBAD-ALB4 was almost identical to that of E. coli harboring pBAD18 (data not shown). This fact suggests that the production of archaeal-type glycerolipids, which differ from endogenous bacterial ones in hydrocarbon structures and in chirality of the glycerol moiety, does not strongly affect the viability of E. coli. The total amount of archaeal-type lipids extracted from E. coli cells, which was estimated by comparing the area of the LC peak at A₂₁₀ with that of known amounts of GGPP, was only ~60 μg/g of wet cells. In addition, the archaeal-type lipids detected in this work, that is, DGGGP-Gro and DGGGOH, still retained double bonds in their hydrocarbon chains, which are rarely found in mature archaeal lipids. Therefore, it appears to be too early to conclude that the coexistence of archaeal and bacterial lipids is not disadvantageous for the organisms.

Acknowledgments

This work was supported by grants-in-aid for scientific research from the Asahi Glass Foundation (for H. H.) and from MEXT, Japan (No. 23108531, for H. Hemmi). The authors thank Dr. Susumu Asakawa, Nagoya University, for his help with the cultivation of M. acetivorans. They thank Mr. Shigeyuki Kitamura, Nagoya University, for his help with LC/ESI-MS analyses.

References

M. De Rosa and A. Gambacorta, “The lipids of archaebacteria,” Progress in Lipid Research, vol. 27, no. 3, pp. 153–175, 1988.

A. Gambacorta, A. Trincone, B. Nicolaus, L. Lama, and M. De Rosa, “Unique features of lipids of Archaea,” Systematic and Applied Microbiology, vol. 16, no. 4, pp. 518–527, 1994.

Y. Koga and H. Morii, “Biosynthesis of ether-type polar lipids in archaea and evolutionary considerations,” Microbiology and Molecular Biology Reviews, vol. 71, no. 1, pp. 97–120, 2007.

J. C. Mathai, G. D. Sprott, and M. L. Zeidel, “Molecular mechanisms of water and solute transport across archaebacterial lipid membranes,” Journal of Biological Chemistry, vol. 276, no. 29, pp. 27266–27271, 2001.

J. L. C. M. van de Vossenberg, A. J. M. Driessen, and W. N. Konings, “The essence of being extremophilic: the role of the unique archaeal membrane lipids,” Extremophiles, vol. 2, no. 3, pp. 163–170, 1998.

Y. Koga, “Early evolution of membrane lipids: how did the lipid divide occur?” Journal of Molecular Evolution, vol. 72, no. 3, pp. 274–282, 2011.

G. Wächtershäuser, “From pre-cells to Eukarya—a tale of two lipids,” Molecular Microbiology, vol. 47, no. 1, pp. 13–22, 2003.

Q. Fan, A. Relini, D. Cassinadri, A. Gambacorta, and A. Gliozzi, “Stability against temperature and external agents of vesicles composed of archaeal bolaform lipids and egg PC,” Biochimica et Biophysica Acta, vol. 1240, no. 1, pp. 83–88, 1995.

H. Shimada and A. Yamagishi, “Stability of heterochiral hybrid membrane made of bacterial sn-G3P lipids and archaeal sn-G1P lipids,” Biochemistry, vol. 50, no. 19, pp. 4114–4120, 2011.

D. Lai, B. Lluncor, I. Schröder, R. P. Gunsalus, J. C. Liao, and H. G. Monbouquette, “Reconstruction of the archaeal isoprenoid ether lipid biosynthesis pathway in Escherichia coli through digeranylgeranylglyceryl phosphate,” Metabolic Engineering, vol. 11, no. 3, pp. 184–191, 2009.

J. Sambrook, Molecular Cloning, A Laboratory Manual, 2nd edition, 1989.

H. Fujii, T. Koyama, and K. Ogura, “Efficient enzymatic hydrolysis of polyprenyl pyrophosphates,” Biochimica et Biophysica Acta, vol. 712, no. 3, pp. 716–718, 1982.

H. Hemmi, K. Shibuya, Y. Takahashi, T. Nakayama, and T. Nishino, “(S)-2,3-Di-O-geranylgeranylglyceryl phosphate synthase from the thermoacidophilic archaeon Sulfolobus solfataricus: molecular cloning and characterization of a membrane-intrinsic prenyltransferase involved in the biosynthesis of archaeal ether-linked membrane lipids,” Journal of Biological Chemistry, vol. 279, no. 48, pp. 50197–50203, 2004.

Y. Koga, T. Kyuragi, M. Nishihara, and N. Sone, “Did archaeal and bacterial cells arise independently from noncellular precursors? A hypothesis stating that the advent of membrane phospholipid with enantiomeric glycerophosphate backbones caused the separation of the two lines of descent,” Journal of Molecular Evolution, vol. 46, no. 1, pp. 54–63, 1998.

S. I. Ohnuma, M. Suzuki, and T. Nishino, “Archaebacterial ether-linked lipid biosynthetic gene. Expression cloning, sequencing, and characterization of geranylgeranyl-diphosphate synthase,” Journal of Biological Chemistry, vol. 269, no. 20, pp. 14792–14797, 1994.

T. Soderberg, A. Chen, and C. D. Poulter, “Geranylgeranylglyceryl phosphate synthase. Characterization of the recombinant enzyme from Methanobacterium thermoautotrophicum,” Biochemistry, vol. 40, no. 49, pp. 14847–14854, 2001.

A. Chen, D. Zhang, and C. D. Poulter, “(S)-geranylgeranylglyceryl phosphate synthase. Purification and characterization of the first pathway-specific enzyme in archaebacterial membrane lipid biosynthesis,” Journal of Biological Chemistry, vol. 268, no. 29, pp. 21701–21705, 1993.

N. Nemoto, T. Oshima, and A. Yamagishi, “Purification and characterization of geranylgeranylglyceryl phosphate synthase from a thermoacidophilic archaeon, Thermoplasma acidophilum,” Journal of Biochemistry, vol. 133, no. 5, pp. 651–657, 2003.

D. Zhang and C. Dale Poulter, “Biosynthesis of archaebacterial ether lipids. Formation of ether linkages by prenyltransferases,” Journal of the American Chemical Society, vol. 115, no. 4, pp. 1270–1277, 1993.

C. Miyazaki, M. Kuroda, A. Ohta, and I. Shibuya, “Genetic manipulation of membrane phospholipid composition in Escherichia coli: pgsA mutants defective in phosphatidylglycerol synthesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 82, no. 22, pp. 7530–7534, 1985.

J. E. Cronan and P. R. Vagelos, “Metabolism and function of the membrane phospholipids of Escherichia coli,” Biochimica et Biophysica Acta, vol. 265, no. 1, pp. 25–60, 1972.

H. Morii and Y. Koga, “CDP-2,3-di-O-geranylgeranyl-sn-glycerol:L-serine O-archaetidyltransferase (archaetidylserine synthase) in the methanogenic archaeon Methanothermobacter thermautotrophicus,” Journal of Bacteriology, vol. 185, no. 4, pp. 1181–1189, 2003.

B. J. Jackson, J. P. Bohin, and E. P. Kennedy, “Biosynthesis of membrane-derived oligosaccharides: characterization of mdoB mutants defective in phosphoglycerol transferase I activity,” Journal of Bacteriology, vol. 160, no. 3, pp. 976–981, 1984.

B. J. Jackson and E. P. Kennedy, “The biosynthesis of membrane-derived oligosaccharides. A membrane-bound phosphoglycerol transferase,” Journal of Biological Chemistry, vol. 258, no. 4, pp. 2394–2398, 1983.